Penile Length Restoration in Men With Diabetes Mellitus, Type II
| Status: | Recruiting |
|---|---|
| Conditions: | Diabetes, Diabetes |
| Therapuetic Areas: | Endocrinology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 12/2/2018 |
| Start Date: | November 7, 2018 |
| End Date: | November 2021 |
| Contact: | Brett Milazzo |
| Email: | milazzo.brett@mayo.edu |
| Phone: | 507-538-6151 |
The objective of the current study is to evaluate the efficacy of a novel penile traction
device in restoring penile length loss secondary to diabetes mellitus.
device in restoring penile length loss secondary to diabetes mellitus.
Men with diabetes mellitus experience sexual dysfunctions at an earlier age and higher rate
compared to men without diabetes. One of these sexual dysfunctions includes diminished penile
length. It is currently unknown if the decreased length is due to earlier erectile
dysfunction or secondary to diabetes itself. Penile traction therapy is one of several
treatments which have been used historically to treat decreased penile length, however, to
date, no studies have evaluated the role of traction therapy in men with diabetes. To
accomplish the study, a population of men from Mayo Clinic with a diagnosis of diabetes, type
II will be enrolled and will be randomized to utilize the device for varying amounts of time.
Outcomes will be assessed at the 3 and 6 month time points, and the results are to be used
with the intent to publish in a scientific journal.
compared to men without diabetes. One of these sexual dysfunctions includes diminished penile
length. It is currently unknown if the decreased length is due to earlier erectile
dysfunction or secondary to diabetes itself. Penile traction therapy is one of several
treatments which have been used historically to treat decreased penile length, however, to
date, no studies have evaluated the role of traction therapy in men with diabetes. To
accomplish the study, a population of men from Mayo Clinic with a diagnosis of diabetes, type
II will be enrolled and will be randomized to utilize the device for varying amounts of time.
Outcomes will be assessed at the 3 and 6 month time points, and the results are to be used
with the intent to publish in a scientific journal.
Inclusion Criteria:
- Men with Diabetes Mellitus, Type II
- 18 years of age or older
Exclusion Criteria:
- Any evidence of end-organ failure attributed to Diabetes (loss of fingers/toes)
- CKD Stage IV or greater
- Retinopathy
- Myocardial infarction
- Cerebrovascular accident
- Indwelling penile prosthesis or prior history of penile prosthesis
- Peyronie's Disease at baseline
We found this trial at
1
site
200 First Street SW
Rochester, Minnesota 55905
Rochester, Minnesota 55905
507-284-2511
Phone: 507-538-6151
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
Click here to add this to my saved trials
